{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T23:02:27Z","timestamp":1775084547593,"version":"3.50.1"},"reference-count":64,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"24","license":[{"start":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:00:00Z","timestamp":1718323200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6,14]]},"abstract":"<jats:p>The aim of this study is to describe the general information, disease and treatment of venous thromboembolism (VTE) in critically ill patients, to explore the characteristics of severe patients with deep venous VTE and provide clinical reference data for the prevention and treatment of VTE in critically ill patients. This study carried out a retrospective study on the medical records of patients who were treated in the intensive care unit of Affiliated Hospital of Jining Medical College from 2020 to 2022. The general data, general conditions, drug use, past history, VTE prevention measures, post-VTE conditions, and Padua risk score of 297 patients with VTE during the period of hospitalization in intensive care unit (ICU) were classified and statistically analyzed. A total of 297 including 171 male and 126 male patient medical records were included in the analysis, we compared multiple clinical indicators between male and female patients. Compared to women, male patients have a higher acute physiology and chronic health evaluation II score(APACHE-II score) (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.027), a higher state of consciousness (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.003), a higher rate of smoking and drinking history (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001), a lower rate of heart failure (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.003) and chronic depression (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.013), and a higher rate of recommended operations for male patients after VTE (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.031). The prothrombin time (PT) (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.041) and activated partial thromboplastin time (APTT) (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.040) of male patients were significantly higher than those of female patients, while triglyceride (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.009) and total cholesterol (TC) (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.001) were significantly lower than those of female patients. The difference in D-dimer (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.739) was not significant. This study shows that male and female patients with VTE in the ICU have significant differences in general characteristics, general clinical conditions, history of past illness, thrombosis character, and examination items, this may be the reason for the different rates of VTE between male and female patients in the ICU.<\/jats:p>","DOI":"10.1097\/md.0000000000038423","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T18:08:55Z","timestamp":1718388535000},"page":"e38423","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["The impact of gender differences on the clinical characteristics of critically ill patients with venous thromboembolism: A retrospective, observational study"],"prefix":"10.1097","volume":"103","author":[{"given":"Meng","family":"He","sequence":"first","affiliation":[{"name":"Department of Prehospital Emergency, Affiliated Hospital of Jining Medical University, Jining, Shandong, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiuhang","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Affiliated Hospital of Jining Medical University, Jining, Shandong, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Affiliated Hospital of Jining Medical University, Jining, Shandong, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Qiao","sequence":"additional","affiliation":[{"name":"Department of Emergency Intensive Care Unit, Affiliated Hospital of Jining Medical University, Jining, Shandong, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Gu","sequence":"additional","affiliation":[{"name":"Emergency Internal Medicine Ward, Affiliated Hospital of Jining Medical University, Jining, Shandong, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenwen","family":"Qin","sequence":"additional","affiliation":[{"name":"Emergency Internal Medicine Ward, Affiliated Hospital of Jining Medical University, Jining, Shandong, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2875-8132","authenticated-orcid":false,"given":"Xuehong","family":"He","sequence":"additional","affiliation":[{"name":"Department of Nursing, Affiliated Hospital of Jining Medical University, Jining, Shandong, P. R. China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"13176","DOI":"10.3390\/ijms232113176","article-title":"Immunothrombosis and the role of platelets in venous thromboembolic diseases.","volume":"23","author":"Heestermans","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/jth.15626","article-title":"Rosuvastatin treatment decreases plasma procoagulant phospholipid activity after a VTE: A randomized controlled trial.","volume":"20","author":"Ramberg","year":"2022","journal-title":"J Thromb Haemost"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s11239-019-01995-7","article-title":"Self-rated health and venous thromboembolism among middle-aged women: a population-based cohort study.","volume":"49","author":"Nymberg","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41569-022-00787-6","article-title":"Epidemiology and prevention of venous thromboembolism.","volume":"20","author":"Lutsey","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1538-7836.2011.04588.x","article-title":"Comparison of associations of adherence to a Dietary Approaches to Stop Hypertension (DASH)-style diet with risks of cardiovascular disease and venous thromboembolism.","volume":"10","author":"Fitzgerald","year":"2012","journal-title":"J Thromb Haemost"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"e5776","DOI":"10.1097\/MD.0000000000005776","article-title":"Factors predicting venous thromboembolism after spine surgery.","volume":"95","author":"Wang","year":"2016","journal-title":"Medicine (Baltim)"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3904\/kjim.2018.097","article-title":"Long-term rivaroxaban for the treatment of acute venous thromboembolism in patients with active cancer in a prospective multicenter trial.","volume":"34","author":"Yhim","year":"2019","journal-title":"Korean J Intern Med"},{"key":"R8-20250503","first-page":"100392","article-title":"One-year incidences of venous thromboembolism, bleeding, and death in patients with lung cancer (Cancer-VTE Subanalysis).","volume":"3","author":"Awano","year":"2022","journal-title":"JTO Clin Res Rep"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"e31162","DOI":"10.1097\/MD.0000000000031162","article-title":"Integrative analyses of genes about venous thromboembolism: an umbrella review of systematic reviews and meta-analyses.","volume":"101","author":"Lee","year":"2022","journal-title":"Medicine (Baltim)"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1089\/jwh.2020.8536","article-title":"Contraceptive preference, continuation rates, and unintended pregnancies in patients with comorbidities: a prospective cohort study.","volume":"30","author":"Leroy-Melamed","year":"2021","journal-title":"J Womens Health (Larchmt)"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1055\/a-1669-4987","article-title":"Oral anticoagulation timing in patients with acute ischemic stroke and atrial fibrillation.","volume":"122","author":"Chang","year":"2022","journal-title":"Thromb Haemost"},{"key":"R12-20250503","first-page":"e32308","article-title":"Increased risk of cardiovascular diseases in rheumatoid arthritis: a systematic review.","volume":"14","author":"Farhat","year":"2022","journal-title":"Cureus"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/a-1891-8158","article-title":"Transgender medicine and risk of venous thromboembolism.","volume":"42","author":"Bunderen","year":"2022","journal-title":"Hamostaseologie"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"900991","DOI":"10.3389\/fneur.2022.900991","article-title":"Uncommon female-predominant etiologies of cryptogenic stroke.","volume":"13","author":"Dong","year":"2022","journal-title":"Front Neurol"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.3390\/jpm12101604","article-title":"Contemporary biomarkers in pulmonary embolism diagnosis: moving beyond D-Dimers.","volume":"12","author":"Gkana","year":"2022","journal-title":"J Pers Med"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1525-1497.2006.00458.x","article-title":"The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism.","volume":"21","author":"Spencer","year":"2006","journal-title":"J Gen Intern Med"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"1076029620907954","DOI":"10.1177\/1076029620907954","article-title":"The incidence and characteristics of venous thromboembolism in neurocritical care patients: a prospective observational study.","volume":"26","author":"Zhang","year":"2020","journal-title":"Clin Appl Thromb Hemost"},{"key":"R18-20250503","article-title":"Low prevalence of thrombosis prophylaxis dose adjustments highlights implications for patient safety.","volume":"12","author":"Anthony Hawkins","year":"2021","journal-title":"Innov Pharm"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12959-022-00439-2","article-title":"Modern thromboprophylaxis protocol based on guidelines applied in a respiratory intensive care unit: a single-center prospective cohort study.","volume":"20","author":"Tang","year":"2022","journal-title":"Thromb J"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1089\/neur.2021.0037","article-title":"Pharmaceutical venous thrombosis prophylaxis in critically ill traumatic brain injury patients.","volume":"2","author":"Huijben","year":"2022","journal-title":"Neurotrauma Rep"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3390\/genes1030413","article-title":"Programming pluripotent precursor cells derived from Xenopus embryos to generate specific tissues and organs.","volume":"1","author":"Borchers","year":"2010","journal-title":"Genes (Basel)"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1253\/circj.CJ-19-0229","article-title":"Sex differences in clinical characteristics and outcomes of patients with venous thromboembolism - From the COMMAND VTE Registry.","volume":"83","author":"Yoshikawa","year":"2019","journal-title":"Circ J"},{"key":"R23-20250503","first-page":"197","article-title":"Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings.","volume":"21","author":"Binkowska","year":"2022","journal-title":"Prz Menopauzalny"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"1005098","DOI":"10.3389\/fped.2022.1005098","article-title":"Direct oral anticoagulants in pediatric venous thromboembolism: review of approved products rivaroxaban and dabigatran.","volume":"10","author":"Al-Ghafry","year":"2022","journal-title":"Front Pediatr"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1111\/jth.15813","article-title":"Risk factors and predictors for venous thromboembolism in people with ischemic stroke: a systematic review.","volume":"20","author":"Tondel","year":"2022","journal-title":"J Thromb Haemost"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.7150\/jca.89231","article-title":"Clinical and laboratory features of different types of cancer-associated thrombosis.","volume":"14","author":"Liu","year":"2023","journal-title":"J Cancer"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12959-023-00469-4","article-title":"Clinical characteristics of venous thromboembolism onset from severe high altitude pulmonary edema in plateau regions.","volume":"21","author":"Liu","year":"2023","journal-title":"Thrombosis J"},{"key":"R28-20250503","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3390\/medicina59050871","article-title":"Management of postpartum extensive venous thrombosis after second pregnancy.","volume":"59","author":"Tiron","year":"2023","journal-title":"Medicina"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.3390\/cells12182230","article-title":"New high-affinity thrombin aptamers for advancing coagulation therapy: balancing thrombin inhibition for clot prevention and effective bleeding management with antidote.","volume":"12","author":"Ayass","year":"2023","journal-title":"Cells"},{"key":"R30-20250503","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/bjh.16275","article-title":"A randomised controlled trial of extended anticoagulation treatment versus standard treatment for the prevention of recurrent venous thromboembolism (VTE) and post-thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (the ExACT study).","volume":"188","author":"Bradbury","year":"2020","journal-title":"Br J Haematol"},{"key":"R31-20250503","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/onco.13540","article-title":"D-Dimer enhances risk-targeted thromboprophylaxis in ambulatory patients with cancer.","volume":"25","author":"Kumar","year":"2020","journal-title":"Oncologist"},{"key":"R32-20250503","doi-asserted-by":"crossref","first-page":"e36952","DOI":"10.1097\/MD.0000000000036952","article-title":"Presentation of glomerulocystic disease in a young onset diabetes: a case report.","volume":"103","author":"Huang","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"R33-20250503","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3340\/jkns.2016.1010.009","article-title":"Elevated Blood Urea Nitrogen\/Creatinine Ratio is associated with venous thromboembolism in patients with acute ischemic stroke.","volume":"60","author":"Kim","year":"2017","journal-title":"J Korean Neurosurg Soc"},{"key":"R34-20250503","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.3390\/cancers15245887","article-title":"Non-Vitamin K antagonist oral anticoagulants versus low molecular weight heparin for cancer-related venous thromboembolic events: individual patient data meta-analysis.","volume":"15","author":"Yau","year":"2023","journal-title":"Cancers"},{"key":"R35-20250503","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1186\/s12959-023-00576-2","article-title":"Efficacy and safety of anticoagulant for treatment and prophylaxis of VTE patients with renal insufficiency: a systemic review and meta-analysis.","volume":"22","author":"Ma","year":"2024","journal-title":"Thrombosis J"},{"key":"R36-20250503","doi-asserted-by":"crossref","first-page":"e127925","DOI":"10.1172\/jci.insight.127925","article-title":"Damage- and pathogen-associated molecular patterns play differential roles in late mortality after critical illness.","volume":"4","author":"Eppensteiner","year":"2019","journal-title":"JCI Insight"},{"key":"R37-20250503","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/jth.15666","article-title":"Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up.","volume":"20","author":"Larsen","year":"2022","journal-title":"J Thromb Haemost"},{"key":"R38-20250503","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1055\/a-1647-9896","article-title":"Extended Anticoagulant Treatment with Full- or reduced-dose apixaban in patients with cancer-associated venous thromboembolism: rationale and design of the API-CAT Study.","volume":"122","author":"Mahe","year":"2022","journal-title":"Thromb Haemost"},{"key":"R39-20250503","first-page":"103610","article-title":"Safety and efficacy of direct oral anticoagulants in comparison with warfarin across different BMI ranges: a systematic review and meta-analysis.","volume":"77","author":"Almas","year":"2022","journal-title":"Ann Med Surg (Lond)"},{"key":"R40-20250503","doi-asserted-by":"crossref","first-page":"e12722","DOI":"10.1002\/rth2.12722","article-title":"Sex-specific aspects of venous thromboembolism: what is new and what is next?","volume":"6","author":"Scheres","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"R41-20250503","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1093\/eurheartj\/ehaa193","article-title":"Genetic predisposition to smoking in relation to 14 cardiovascular diseases.","volume":"41","author":"Larsson","year":"2020","journal-title":"Eur Heart J"},{"key":"R42-20250503","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1111\/jth.14224","article-title":"Alcohol consumption and the risk of incident pulmonary embolism in US women and men.","volume":"16","author":"Harrington","year":"2018","journal-title":"J Thromb Haemost"},{"key":"R43-20250503","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fnut.2020.00032","article-title":"Alcohol consumption and risk for venous thromboembolism: a meta-analysis of prospective studies.","volume":"7","author":"Chen","year":"2020","journal-title":"Front Nutr"},{"key":"R44-20250503","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12957-022-02705-z","article-title":"The ICU-venous thromboembolism score and tumor grade can predict inhospital venous thromboembolism occurrence in critical patients with tumors.","volume":"20","author":"Mei","year":"2022","journal-title":"World J Surg Oncol"},{"issue":"S1","key":"R45-20250503","doi-asserted-by":"crossref","first-page":"44","DOI":"10.5045\/br.2022.2022025","article-title":"Challenging issues in the management of cancer-associated venous thromboembolism.","volume":"57","author":"Yhim","year":"2022","journal-title":"Blood Res"},{"key":"R46-20250503","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s40620-022-01413-x","article-title":"A systematic review of the efficacy and safety of anticoagulants in advanced chronic kidney disease.","volume":"35","author":"Parker","year":"2022","journal-title":"J Nephrol"},{"key":"R47-20250503","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/bjh.16275","article-title":"A randomised controlled trial of extended anticoagulation treatment versus standard treatment for the prevention of recurrent venous thromboembolism (VTE) and post-thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (the ExACT study).","volume":"188","author":"Bradbury","year":"2020","journal-title":"Br J Haematol"},{"key":"R48-20250503","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/onco.13540","article-title":"D-Dimer enhances risk-targeted thromboprophylaxis in ambulatory patients with cancer.","volume":"25","author":"Kumar","year":"2020","journal-title":"Oncologist"},{"key":"R49-20250503","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/annonc\/mdp354","article-title":"Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial.","volume":"21","author":"Mandala","year":"2010","journal-title":"Ann Oncol"},{"key":"R50-20250503","doi-asserted-by":"crossref","first-page":"e010317","DOI":"10.1161\/JAHA.118.010317","article-title":"Metabolites associated with the risk of incident venous thromboembolism: a metabolomic analysis.","volume":"7","author":"Jiang","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"R51-20250503","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1038\/s41598-023-31067-z","article-title":"A bidirectional Mendelian randomized study of classical blood lipids and venous thrombosis.","volume":"13","author":"Lin","year":"2023","journal-title":"Sci Rep"},{"key":"R52-20250503","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-3083.2005.01683.x","article-title":"Expression of interleukin-17 in ischemic brain tissue.","volume":"62","author":"Li","year":"2005","journal-title":"Scand J Immunol"},{"key":"R53-20250503","doi-asserted-by":"crossref","first-page":"873802","DOI":"10.3389\/fneur.2022.873802","article-title":"Inflammation and severe cerebral venous thrombosis.","volume":"13","author":"Hu","year":"2022","journal-title":"Front Neurol"},{"key":"R54-20250503","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1055\/s-0040-1714350","article-title":"COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure.","volume":"120","author":"Spiezia","year":"2020","journal-title":"Thromb Haemost"},{"key":"R55-20250503","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1055\/s-0040-1710317","article-title":"Hypercoagulation and antithrombotic treatment in coronavirus 2019: a new challenge.","volume":"120","author":"Violi","year":"2020","journal-title":"Thromb Haemost"},{"key":"R56-20250503","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1016\/j.bja.2022.07.040","article-title":"Prevalence of pulmonary embolism and deep venous thrombosis during the COVID-19 pandemic in an intensive care unit cohort: a service evaluation.","volume":"129","author":"Barnett","year":"2022","journal-title":"Br J Anaesth"},{"key":"R57-20250503","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/annonc\/mdp354","article-title":"Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial.","volume":"21","author":"Mandala","year":"2010","journal-title":"Ann Oncol"},{"key":"R58-20250503","doi-asserted-by":"crossref","first-page":"e010317","DOI":"10.1161\/JAHA.118.010317","article-title":"Metabolites associated with the risk of incident venous thromboembolism: a metabolomic analysis.","volume":"7","author":"Jiang","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"R59-20250503","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1038\/s41598-023-31067-z","article-title":"A bidirectional Mendelian randomized study of classical blood lipids and venous thrombosis.","volume":"13","author":"Lin","year":"2023","journal-title":"Sci Rep"},{"key":"R60-20250503","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-3083.2005.01683.x","article-title":"Expression of interleukin-17 in ischemic brain tissue.","volume":"62","author":"Li","year":"2005","journal-title":"Scand J Immunol"},{"key":"R61-20250503","doi-asserted-by":"crossref","first-page":"873802","DOI":"10.3389\/fneur.2022.873802","article-title":"Inflammation and severe cerebral venous thrombosis.","volume":"13","author":"Hu","year":"2022","journal-title":"Front Neurol"},{"key":"R62-20250503","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1055\/s-0040-1714350","article-title":"COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure.","volume":"120","author":"Spiezia","year":"2020","journal-title":"Thromb Haemost"},{"key":"R63-20250503","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1055\/s-0040-1710317","article-title":"Hypercoagulation and antithrombotic treatment in coronavirus 2019: a new challenge.","volume":"120","author":"Violi","year":"2020","journal-title":"Thromb Haemost"},{"key":"R64-20250503","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1016\/j.bja.2022.07.040","article-title":"Prevalence of pulmonary embolism and deep venous thrombosis during the COVID-19 pandemic in an intensive care unit cohort: a service evaluation.","volume":"129","author":"Barnett","year":"2022","journal-title":"Br J Anaesth"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038423","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:41:20Z","timestamp":1746319280000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,14]]},"references-count":64,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000038423","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,14]]}}}